Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.20%
#2 aelf aelf +23.92%
#3 Bitway Bitway +21.89%
#4 Decred Decred +16.39%
#5 Starpower Starpower +11.64%
#6 Pons Pons +11.46%
#7 AtomOne AtomOne +10.65%
#8 TRIA TRIA +9.64%
#9 Wibx Wibx +8.12%
#10 Status Status +7.76%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
설정
언어
한국어
통화
USD
테마
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
주식 순위 #30348
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
주가
$0.93298493
시가총액
$17.19M
변동 (1일)
-1.38%
변동 (1년)
-62.47%
국가
JP
거래 Perseus Proteomics Inc. (4882)

카테고리

Healthcare
Perseus Proteomics Inc. (4882)의 주가 이력
최고 종가: $0.94 (2026-08-01 기준)

최저 종가: $7.34 (2021-06-01 기준)
Perseus Proteomics Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -5.78%
2025 -60.94%
2024 -2.22%
2023 82.81%
2022 -26.01%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.23K 74.37%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $271.04 52.44%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $258.13 25.19%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $477.05 41.32%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.49 59.53%
US